GS 504: Began a second Phase II/III trial

Gilead Sciences Inc. (GILD), Foster City, Calif. Product: GS 504, small-molecule nucleotide analog Indication: Prevent progression of cytomegalovirus infection of the peripheral retina in AIDS patien...